She is an esteemed supervisor and group leader in the Miscellaneous Group, who tirelessly guides and encourages her students in their research. In September, Dr. Emese Sipter was named Supervisor of the Month (Year 1) at the Centre for Translational Medicine.
Dr. Sipter, an expert in diabetology, joined the CTM team as a supervisor and group leader this academic year. She is a diabetologist, lipidologist, and obesitologist at the Department of Internal Medicine and Haematology, Semmelweis University, focusing mostly on metabolic diseases. As a supervisor, she dedicates her time to support three Ph.D. students, providing them with unwavering guidance and encouragement throughout their research.
„The specialists at the Centre of Excellence for Pancreatic Diseases have been contacting me for years about patient consultations, and thanks to them, I learned about the Ph.D. program of the CTM. I found the program very supportive and I was impressed by the team’s motivation and ability to motivate others, including clinicians. For me, it was new that the training was teamwork, and there were weekly group meetings instead of individual discussions. I find this a very effective way to achieve scientific results.”
Dr. Sipter’s students are doing research in the field of diabetes. “Gabriella Rákóczi is a nutritionist (MSc) who is investigating the effectiveness of continuous blood glucose monitoring in non-diabetic people. She wants to find out how this method can be used to predict whether a healthy person will develop diabetes later. The reason for this research is that we might identify the metabolic disturbances earlier by continuous blood glucose monitoring. This opportunity would be beneficial because we could help avoiding or delaying the onset of diabetes.” Another student of Dr. Sipter’s is Miaoxin Huang, an advanced practice nurse (MSc), who is investigating the connection between prediabetes and chronic inflammation. The third student is Anca Cristina Dolhascu, a pulmonology resident, who explores the relationship between cystic fibrosis and insulin treatment. She investigates whether insulin treatment has a beneficial effect on the quality of life of patients with cystic fibrosis.
“I find the topics of all three of my students exciting and interesting. We have meetings with my students and our scientific methodology expert on Tuesdays, and we have a meeting with Professor Peter Hegyi on Wednesdays. He helps the students as a supervisor, just like me. On Thursdays, we have group meetings, so we meet three times a week in total. I believe our results will bring a lot of new knowledge to medicine.”
(Szabó Emese)